Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
Clinical trial NCT00001703 · TERMINATED
Trial details
- NCT number
- NCT00001703
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 2008-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.